• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

445
81
51
50
31

COUNTRY

48
19
6
6
6

PRICE

290
536
1,096
1,552

PUBLISHED

65
86
308
1,552

PRODUCT TYPE

1,531
14
5
2

Central Nervous System

(1,552 Products)

In 2012 major changes might revolutionize the treatment of multiple sclerosis, as Gilenya, the first novel drug in five years, will be joined by three new products: BG-12, Aubagio, and Lemtrada. Recent exciting developments in drug discovery might also enhance the hopes of those fighting against Alzheimer.

Great commercial and scientific opportunities are to be found in similar battles against a range of diseases and neurodegenerative disorders, e.g. Parkinson’s disease, schizophrenia, migraine, insomnia, epilepsy, etc.

A wide selection of industry reports, scientific journals and academic textbooks in this section allow readers to explore every conceivable facet of this industry, such as market trends, industry forecasts, new drugs in development, the latest research & development, patent applications, and licensing strategies.

Key players featured in our publications include Biogen Idec, Sanofi, Genzyme, and many more. Show Less
Read more

Ischemic Stroke - Pipeline Review, H2 2014

Ischemic Stroke - Pipeline Review, H2 2014 Summary This, ‘Ischemic Stroke - Pipeline Review, H2 2014’, provides an overview of the Ischemic Stroke’s therapeutic pipeline. This report provides comprehensive...

October 2014
FROM

Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, H2 2014

Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, H2 2014 Summary This, ‘Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, H2 2014’, provides an overview of the Post-Traumatic Stress...

October 2014
FROM

Alzheimer's Disease - Pipeline Review, H2 2014

Alzheimer's Disease - Pipeline Review, H2 2014 Summary This, ‘Alzheimer's Disease - Pipeline Review, H2 2014’, provides an overview of the Alzheimer's Disease’s therapeutic pipeline. This report...

October 2014
FROM

Traumatic Brain Injury - Pipeline Review, H2 2014

Traumatic Brain Injury - Pipeline Review, H2 2014 Summary This, ‘Traumatic Brain Injury - Pipeline Review, H2 2014’, provides an overview of the Traumatic Brain Injury’s therapeutic pipeline. This...

October 2014
FROM

Fibromyalgia - Pipeline Review, H2 2014

Fibromyalgia - Pipeline Review, H2 2014 Summary This, ‘Fibromyalgia - Pipeline Review, H2 2014’, provides an overview of the Fibromyalgia’s therapeutic pipeline. This report provides comprehensive...

October 2014
FROM

Major Depressive Disorder Therapeutics in Major Developed Markets to 2020

Summary: This report provides insights into Major Depressive Disorder (MDD) in the major developed markets of the US, the UK, France, Germany, Italy, Spain, Japan and Canada. The report provides...

October 2014
FROM

Schizophrenia - Pipeline Review, H2 2014

Schizophrenia - Pipeline Review, H2 2014 Summary This, ‘Schizophrenia - Pipeline Review, H2 2014’, provides an overview of the Schizophrenia’s therapeutic pipeline. This report provides comprehensive...

October 2014
FROM

Restless Legs Syndrome - Pipeline Review, H2 2014

Restless Legs Syndrome - Pipeline Review, H2 2014 Summary This, ‘Restless Legs Syndrome - Pipeline Review, H2 2014’, provides an overview of the Restless Legs Syndrome’s therapeutic pipeline. This...

October 2014
FROM

Spasticity - Pipeline Review, H2 2014

Spasticity - Pipeline Review, H2 2014 Summary This, ‘Spasticity - Pipeline Review, H2 2014’, provides an overview of the Spasticity’s therapeutic pipeline. This report provides comprehensive information...

October 2014
FROM

Stroke - Pipeline Review, H2 2014

Stroke - Pipeline Review, H2 2014 Summary This, ‘Stroke - Pipeline Review, H2 2014’, provides an overview of the Stroke’s therapeutic pipeline. This report provides comprehensive information on the...

October 2014
FROM

Parkinson's Disease - Pipeline Review, H2 2014

Parkinson's Disease - Pipeline Review, H2 2014 Summary This, ‘Parkinson's Disease - Pipeline Review, H2 2014’, provides an overview of the Parkinson's Disease’s therapeutic pipeline. This report...

October 2014
FROM

Spinal Stenosis - Pipeline Review, H2 2014

Spinal Stenosis - Pipeline Review, H2 2014 Summary This, ‘Spinal Stenosis - Pipeline Review, H2 2014’, provides an overview of the Spinal Stenosis’s therapeutic pipeline. This report provides comprehensive...

October 2014
FROM

Neuropathic Pain - Pipeline Review, H2 2014

Neuropathic Pain - Pipeline Review, H2 2014 Summary This, ‘Neuropathic Pain - Pipeline Review, H2 2014’, provides an overview of the Neuropathic Pain’s therapeutic pipeline. This report provides...

October 2014
FROM

Amyotrophic Lateral Sclerosis - Pipeline Review, H2 2014

Amyotrophic Lateral Sclerosis - Pipeline Review, H2 2014 Summary This, ‘Amyotrophic Lateral Sclerosis - Pipeline Review, H2 2014’, provides an overview of the Amyotrophic Lateral Sclerosis’s therapeutic...

October 2014
FROM

Anesthetic Effect - Pipeline Review, H2 2014

Anesthetic Effect - Pipeline Review, H2 2014 Summary This, ‘Anesthetic Effect - Pipeline Review, H2 2014’, provides an overview of the Anesthetic Effect’s therapeutic pipeline. This report provides...

October 2014
FROM

Multiple Sclerosis - Pipeline Review, H2 2014

Multiple Sclerosis - Pipeline Review, H2 2014 Summary This, ‘Multiple Sclerosis - Pipeline Review, H2 2014’, provides an overview of the Multiple Sclerosis’s therapeutic pipeline. This report provides...

September 2014
FROM

Cognitive Impairment - Pipeline Review, H2 2014

Cognitive Impairment - Pipeline Review, H2 2014 Summary This, ‘Cognitive Impairment - Pipeline Review, H2 2014’, provides an overview of the Cognitive Impairment’s therapeutic pipeline. This report...

September 2014
FROM

Autism - Pipeline Review, H2 2014

Autism - Pipeline Review, H2 2014 Summary This, ‘Autism - Pipeline Review, H2 2014’, provides an overview of the Autism’s therapeutic pipeline. This report provides comprehensive information on the...

September 2014
FROM

Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H2 2014

Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H2 2014 Summary This, ‘Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H2 2014’, provides an overview of the Relapsing...

September 2014
FROM

Partial Seizure - Pipeline Review, H2 2014

Partial Seizure - Pipeline Review, H2 2014 Summary This, ‘Partial Seizure - Pipeline Review, H2 2014’, provides an overview of the Partial Seizure’s therapeutic pipeline. This report provides comprehensive...

September 2014
FROM
Loading Indicator

Our Clients

Shire PLC. GlaxoSmithKline PLC Astrazeneca PLC Roche Diagnostics Ltd. H. Lundbeck A/S Electrical Geodesics, Inc.